Clare Davies is a Reader of Cancer Cell Biology in the Department of Cancer and Genomic Sciences, where her research is focused on understanding the role of PRMTs, enzymes that catalyse methylation of arginine residues, in cancer pathogenesis. This is important as inhibitors to specific PRMTs are in pre-clinical development for cancer therapy.
Clare started her research group in 2012 as a ...